175 related articles for article (PubMed ID: 1528270)
21. N-methyl-D-aspartate increases the excitability of nigrostriatal dopamine terminals.
Overton P; Clark D
Eur J Pharmacol; 1991 Aug; 201(1):117-20. PubMed ID: 1794413
[TBL] [Abstract][Full Text] [Related]
22. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
Santiago M; Westerink BH
Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125
[TBL] [Abstract][Full Text] [Related]
23. Differential control by N-methyl-D-aspartate and kainate of striatal dopamine release in vivo: a trans-striatal dialysis study.
Carter CJ; L'Heureux R; Scatton B
J Neurochem; 1988 Aug; 51(2):462-8. PubMed ID: 2899132
[TBL] [Abstract][Full Text] [Related]
24. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
[TBL] [Abstract][Full Text] [Related]
25. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the mechanisms underlying the kainate-induced impairment of [3H]dopamine release in the rat striatum.
Fedele E; Versace P; Raiteri M
Eur J Pharmacol; 1993 Nov; 249(1):71-7. PubMed ID: 7506667
[TBL] [Abstract][Full Text] [Related]
27. NMDA and non-NMDA receptor-mediated release of [3H]GABA from granule cell dendrites of rat olfactory bulb.
García Y; Ibarra C; Jaffé EH
J Neurochem; 1995 Feb; 64(2):662-9. PubMed ID: 7530292
[TBL] [Abstract][Full Text] [Related]
28. Muscarinic potentiation of excitatory amino acid-evoked dopamine release in mesencephalic cells: specificity for the NMDA response and role of intracellular messengers.
Allaoua H; Chaudieu I; Alonso R; Quirion R; Boksa P
Synapse; 1993 Sep; 15(1):39-47. PubMed ID: 8310424
[TBL] [Abstract][Full Text] [Related]
29. In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-D-aspartate-evoked striatal dopamine release and effects of antagonists.
Carrozza DP; Ferraro TN; Golden GT; Reyes PF; Hare TA
Brain Res; 1992 Mar; 574(1-2):42-8. PubMed ID: 1353403
[TBL] [Abstract][Full Text] [Related]
30. Presynaptic glutamate receptors facilitate release of norepinephrine and 5-hydroxytryptamine as well as dopamine in the normal and ischemic striatum.
Ohta K; Fukuuchi Y; Shimazu K; Komatsumoto S; Ichijo M; Araki N; Shibata M
J Auton Nerv Syst; 1994 Sep; 49 Suppl():S195-202. PubMed ID: 7836679
[TBL] [Abstract][Full Text] [Related]
31. Met-enkephalin release from slices of the rat striatum and globus pallidus: stimulation by excitatory amino acids.
Ruzicka BB; Jhamandas K
J Pharmacol Exp Ther; 1991 Jun; 257(3):1025-33. PubMed ID: 1675284
[TBL] [Abstract][Full Text] [Related]
32. Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors.
Marti M; Mela F; Bianchi C; Beani L; Morari M
J Neurochem; 2002 Nov; 83(3):635-44. PubMed ID: 12390525
[TBL] [Abstract][Full Text] [Related]
33. Presynaptic facilitation of dopamine release through D,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors on synaptosomes from the rat striatum.
Desce JM; Godeheu G; Galli T; Artaud F; Chéramy A; Glowinski J
J Pharmacol Exp Ther; 1991 Nov; 259(2):692-8. PubMed ID: 1682483
[TBL] [Abstract][Full Text] [Related]
34. 1-Hydroxy-3-aminopyrrolid-2-one (HA-966) and kynurenate antagonize N-methyl-D-aspartate induced enhancement of [3H]dopamine release from rat striatal slices.
Crawford M; Roberts PJ
Biochem Pharmacol; 1989 Dec; 38(23):4165-8. PubMed ID: 2688655
[TBL] [Abstract][Full Text] [Related]
35. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
Santiago M; Westerink BH
J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
[TBL] [Abstract][Full Text] [Related]
36. Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids.
Keefe KA; Sved AF; Zigmond MJ; Abercrombie ED
J Neurochem; 1993 Nov; 61(5):1943-52. PubMed ID: 7901337
[TBL] [Abstract][Full Text] [Related]
37. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.
Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544
[TBL] [Abstract][Full Text] [Related]
38. In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids.
Keefe KA; Zigmond MJ; Abercrombie ED
J Neural Transm Gen Sect; 1993; 91(2-3):223-40. PubMed ID: 8099798
[TBL] [Abstract][Full Text] [Related]
39. Riluzole blocks dopamine release evoked by N-methyl-D-aspartate, kainate, and veratridine in the rat striatum.
Keita H; Lepouse C; Henzel D; Desmonts JM; Mantz J
Anesthesiology; 1997 Nov; 87(5):1164-71. PubMed ID: 9366469
[TBL] [Abstract][Full Text] [Related]
40. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.
Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
